Advertisement

ICU Medical, Inc. ICUI

Set alert

Price alert · ICUI

All alert types
163.78 USD -4.87 -2.89%

At close · Oct 30

163.78 0.00 0.00%

After hours · Oct 30, 4:00 PM ET

Bid
163.78 × 2
Ask
163.94 × 2
163.15 Day range 167.90
115.45 52-week range 187.26
YTD
+14.80%
1 year
+36.78%
Open
167.90
Prev close
168.65
Mkt cap
4.10B
Vol
216.56K
Avg vol
261.90K
EPS
1.19
P/E
137.63
Div yield
0.00%
More statistics
Low
163.15
High
167.90
Forward P/E
16.97
Beta
0.86
Short ratio
6.84
Inst. own
115.92%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
164.60
200-d avg
148.52
1y target
193.38

5D chart

Chart tools
Interval
ICUI five-day price chart161.4163.4165.5167.6169.7Oct 26Oct 27Oct 28Oct 29Oct 30

Key statistics

Market cap
4.09B
Enterprise value
5.20B
Trailing P/E
137.60
Forward P/E
16.97
PEG ratio
0.08
Price / sales
1.90
Price / book
1.90
EPS (TTM)
1.19
Beta
0.86
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
1.39%
Revenue (TTM)
2.16B
Revenue growth
0.50%
Free cash flow
163.56M
Total cash
302.64M
Total debt
1.29B
Return on equity
1.41%
Shares outstanding
25.01M
Short % of float
8.20%
50-day average
164.60
200-day average
148.52

Analyst view

Consensus: buy

Buy
Price target (mean) 193.38 +18.1% upside
Target (low)
178.00
Target (mean)
193.38
Target (high)
210.00
Ratings (0m) 8 7 buy · 1 hold · 0 sell
  • Strong buy3
  • Buy4
  • Hold1
  • Sell0
  • Strong sell0

Next earnings

Nov 5, 2026

Expected Nov 5, 2026. Consensus EPS estimate 2.15.

Earnings history

Financials — quick view

All financials
ICUI Revenue — quarterly 551.68M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
ICUI Net income — quarterly 19.09M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
ICUI EPS — quarterly 0.76
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

ICUI recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 5, 2026Sep 30, 20262.14———
Aug 6, 2026Jun 30, 20261.912.37+0.46+24.08%
May 7, 2026Mar 31, 20261.781.97+0.19+10.67%
Feb 19, 2026Dec 31, 20251.681.91+0.23+13.69%
Nov 6, 2025Sep 30, 20251.432.03+0.60+41.96%
Aug 7, 2025Jun 30, 20251.442.10+0.66+45.83%

Upgrades / downgrades

ICUI analyst upgrades and downgrades
DateFirmActionFromTo
Aug 7, 2026Piper SandlermainOverweightOverweight
Aug 7, 2026BTIGmainBuyBuy
Aug 7, 2026NeedhammainBuyBuy
Jul 21, 2026KeybancmainOverweightOverweight
Jun 15, 2026BTIGinit—Buy
May 27, 2026NeedhamupHoldBuy

About ICU Medical, Inc.

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States
Website
icumed.com

News

Your note

Sign in to keep a note on ICUI — it syncs with the Stock Master app.

Insider holders

ICUI insider holders
InsiderRelationLatest transactionDateShares held
ABBEY DONALD MDirectorConversion of Exercise of derivative securityMay 12, 20266,004
BONNELL BRIAN MICHAELChief Financial OfficerSaleAug 31, 202656,062
FINNEY ELISHA WDirectorSaleAug 10, 20264,871
GREENBERG DAVID CDirectorConversion of Exercise of derivative securityMay 12, 20269,214
HERNANDEZ LAURIEDirectorConversion of Exercise of derivative securityMay 12, 20264,862
HOFFMEISTER DAVID FDirectorConversion of Exercise of derivative securityMay 12, 20266,004

Institution ownership

ICUI institution ownership
Holder% heldSharesValueReported
Blackrock Inc.15.02%3,753,409614.60MJun 29, 2026
Jupiter Topco LLC11.13%2,781,620455.48MJun 29, 2026
Vanguard Portfolio Management LLC5.88%1,470,583240.80MJun 29, 2026
Fuller & Thaler Asset Management Inc.5.19%1,298,127212.56MJun 29, 2026
Vanguard Capital Management LLC4.49%1,123,237183.92MJun 29, 2026
Dimensional Fund Advisors LP4.21%1,053,476172.50MJun 29, 2026

Fund ownership

ICUI fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Small-Cap ETF5.96%1,489,253243.86MSep 29, 2026
JANUS INVESTMENT FUND-Janus Henderson Enterprise Fund4.92%1,230,753201.53MJun 29, 2026
UNDISCOVERED MANAGERS Fd.S-Undiscovered Managers Behavioral Value Fd.4.22%1,054,324172.64MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.17%791,929129.67MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.57%641,126104.98MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.29%573,52293.91MJun 29, 2026
Advertisement